+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phase I study of carboplatin and vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer



Phase I study of carboplatin and vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer



Journal of Investigative Medicine 48(5): 266A




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 035489534

Download citation: RISBibTeXText

DOI: 10.1016/s0169-5002(00)80347-5


Related references

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Lung Cancer 38(1): 65-71, 2002

A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 2(9): 831-837, 2007

A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology 24(18_suppl): 7146-7146, 2016

Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I/II study. Oncologist 6 Suppl 1: 12-15, 2001

Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer. Lung Cancer 12(3): 247-257, 1995

A randomized phase II trial of cisplatinum plus mitomycin-C plus vinorelbine and carboplatin plus vinorelbine in advanced non-small cell lung cancer. International Journal of Oncology 10(3): 619-622, 1997

Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer. Anticancer Research 31(1): 317-323, 2011

A phase I/II study of vinorelbine (NAV) and carboplatin (CARB) for advanced non-small cell lung cancer (NSCLC). Lung Cancer 29(1): 54-55, 2000

Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study. American Journal of Clinical Oncology 21(1): 67-71, 1998

Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study. American Journal of Clinical Oncology 22(1): 57-61, 1999

Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study. Clinical Lung Cancer 12(2): 100-105, 2011

A modified Phase I trial of radiation dose escalation in 3D conformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer. Journal of Radiation Research 54(1): 126-134, 2013

Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer. Molecular and Clinical Oncology 2(3): 405-410, 2014

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): A FONICAP randomized phase II study. British Journal of Cancer 77(12): 2367-2370, 1998

Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study. Lung Cancer 34 Suppl 4: S77-S80, 2001